| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |